| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&P also fell, dropping 0.01% to 4,246.07.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,486,910 cases with around 600,280 deaths. India confirmed a total of at least 29,633,100 cases and 379,570 deaths, while Brazil reported over 17,533,220 COVID-19 cases with 490,690 deaths. In total, there were at least 176,682,210 cases of COVID-19 worldwide with more than 3,823,780 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Health care shares climbed 0.6% on Wednesday. Meanwhile, top gainers in the sector included Kindred Biosciences, Inc. (NASDAQ:KIN), up 45%, and Aprea Therapeutics, Inc. (NASDAQ:APRE), up 38%.
In trading on Wednesday, energy shares fell 1%.
Top Headline
Elanco Animal Health Incorporated (NYSE:ELAN) agreed to acquire Kindred Biosciences Inc (NASDAQ:KIN) for $9.25 per share, or approximately $440 million.
The price represents a premium of 52% based on the 30-day average.
Equities Trading UP
Kindred Biosciences, Inc. (NASDAQ:KIN) shares shot up 45% to $9.19 after Elanco announced an agreement to acquire the company for $9.25 per share.
Shares of Aprea Therapeutics, Inc. (NASDAQ:APRE) got a boost, shooting 43% to $6.95 after the company announced that the Phase 1/2 trial evaluating eprenetapopt in acute myeloid leukemia (AML) has met the pre-specified primary efficacy endpoint of complete remission (CR) rate.
GTT Communications, Inc. (NYSE:GTT) shares were also up, gaining 37% to $2.8101.
Check out these big movers of the day
Equities Trading DOWN
Alzamend Neuro, Inc. (NASDAQ:ALZN) shares tumbled 15% to $11.50. Alzamend Neuro shares jumped 170% on Tuesday after the company priced its IPO at $5 per share
Shares of Inhibikase Therapeutics, Inc. (NASDAQ:IKT) were down 22% to $3.1350 after the company priced an underwritten public offering of 15 million shares at $3/share for gross proceeds of approximately $45 million.
Blue Apron Holdings, Inc. (NYSE:APRN) was down, falling 19% to $4.4750 after the company priced public offering of 4.706 million shares of Class A common stock at $4.25 per share.
Commodities
In commodity news, oil traded up 0.5% to $72.45, while gold traded up 0.1% to $1,857.10.
Silver traded up 0.6% Wednesday to $27.87 while copper rose 0.1% to $4.3330.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 gained 0.1%, the Spanish Ibex Index fell 0.1% and the German DAX 30 fell 0.1%. Meanwhile, the London’s FTSE 100 gained 0.1%, French CAC 40 climbed 0.1% and Italy’s FTSE MIB rose 0.1%.
UK’s producer prices rose 4.6% year-on-year in May, while consumer price inflation rate increased to 2.1% year-over-year.
Economics
Housing starts rose 3.6% to an annualized rate of 1.572 million in May, while building permits fell 3.0% to a 1.681 million rate.
US import prices increased 1.1% in May, while prices for exports climbed 2.2%.
The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.
The Federal Reserve will announce its policy decision at 2:00 p.m. ET.
The Fed Chairman Jerome Powell will hold a press conference at 2:30 p.m. ET.
